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Objectives: The aim of this study is to determine a set of MRI lymph node characteristics predictive for
extranodal tumor spread (ENS) in head and neck cancer patients.
Methods: In 39 patients, 60 lymph nodes with on MRI a minimal axial diameter of more than 1 cm or an
inhomogeneous enhancement were studied. Two radiologists evaluated all MR-images for ﬁndings
potentially indicative of the presence of ENS. Sensitivity, speciﬁcity and odds ratios based on logistic
regression were calculated.
Results: OnMR-imaging, 20 lymph nodes were staged positive for ENS. On histopathology, 30 nodes were
positive for ENS. In total, 14 nodes (23%) were scored differently on MR-imaging and histopathology. The
MR-ﬁnding ‘‘inﬁltration of adjacent planes’’ established a speciﬁcity of 100% (lower 90% conﬁdence
bound: 91%) and sensitivity of 50% (95% conﬁdence interval [CI]: 28–72%).
Conclusion: The MRI ﬁnding ‘‘inﬁltration of adjacent planes’’ may be high enough (100% in our study) to
be used for treatment planning.
 2013 Elsevier Ltd. Open access under the Elsevier OA license. Introduction
Extranodal tumor spread (ENS) of lymph node metastases from
head and neck cancer is a signiﬁcant prognostic factor for locore-
gional control, distant metastases free survival and overall
survival.1–4 A meta-analysis by Dunne et al.5 showed a 5-year-
survival rate between 17% and 55.8% for neck metastases with
ENS and 44.6–76% for patients with neck metastases without ENS.
ENS in multiple lymph nodes is presumed even to be a worse
prognostic sign.6 As a result, ENS is widely accepted to be a criterion
for postoperative radiotherapy and concurrent chemoradiation
therapy (CCRT).7 In fact, ENS is believed to be the most important
prognostic factor in patients with cervical metastases both in
relation to locoregional recurrence and distant metastases.8–10
As ENS is accepted as a criterion for postoperative CCRT, and
CCRT without surgery (primary resection of the tumor combined
with neck dissection) has probably similar cure rate as surgery plusolaryngology/Head and Neck
enter Groningen, Groningen,
r).
sevier OA license. radiotherapy, the role of surgery in these patients is disputable.7,11
If ENS can be diagnosed at preoperative MRI, treatment can be pri-
marily directed towards CCRT and surgery can be kept in reserve
for salvage. In literature, with the use of different MR-ﬁndings
(appearance of inﬁltration of adjacent planes, central nodal necrosis,
short axis diameter or capsular contour irregularity), sensitivity
ranges from 65% to 95% and speciﬁcity ranges from 72% to
100%12–16 without speciﬁcation of the various parameters used. A
possible explanation for different percentages of sensitivity and
speciﬁcity found in literature could be the increasing quality of
available CT and MRI scanners overtime. However, another possi-
ble cause of this difference could be created by variation in ENS
determination in histology reports. A recent publication of van
den Brekel et al.17 shows that consensus among pathologists on
ENS (the current gold standard) is not satisfactory (inter-observer
variability kappa = 0.44).
Several studies tried to identify a set of radiological characteris-
tics predictive for ENS on both CT and MR imaging.8,18 These char-
acteristics included: capsular contour irregularity and/or
inﬁltration of adjacent planes; presence of non-contrast enhancing
parts inside a lymph node; irregular contrast enhancement and
central nodal necrosis.12,15,16,18–21
Table 1
Patient and tumor characteristics.
Patients characteristics N = 39 (total 60 nodes)
Sex
Men 25 (64%)
Women 14 (36%)
Age (range; median) 46–85 year (63)
Primary tumor characteristics
Site
Oral Cavity 23 (59%)
Oropharynx 5 (13%)
W.L. Lodder et al. / Oral Oncology 49 (2013) 626–633 627As far as the histological criteria for ENS are concerned the Royal
College of Pathologists22 published in 2005 the second edition of
datasets for histopathology reports on head and neck carcinomas
while in 2009, the American College of Pathologists23 published
their latest guidelines for ENS on head and neck carcinomas.
The aim of this study is to determine a set of MRI lymph node
characteristics predictive for ENS of metastatic head and neck
squamous cell carcinoma, based upon the previously used criteria
in literature and correlate them with clearly deﬁned histological
observations.Hypopharynx 1 (2%)
Larynx 0 (0%)
Unknown primary tumor 10 (26%)
Pathological T-stage
T1 8 (20%)
T2 10 (26%)
T3 5 (13%)
T4 6 (15%)
Tx 10 (26%)
Pathological N-stageMaterials and methods
Ethical considerations
For this study institutional approval was obtained. For the ret-
rospective review of records and images patient consent was not
required, as patient anonymity was preserved.N1 5 (13%)
N2a 6 (15%)
N2b 21 (54%)
N2c 3 (8%)
N3 4 (10%)Patients
This study was performed retrospectively, however all images
and lymph nodes were re-evaluated. All patients who had under-
gone primary neck dissection for head and neck squamous cell car-
cinoma together with MRI, prior to surgery in our institute,
between 2007 and 2010, were selected. In our center, patients with
a tumor located above the level of the hyoid bone or with an un-
known primary tumor are studied with MR imaging. A total of
44 patients resulted after the ﬁrst selection of patients with both
MR images and neck dissection between 2007 and 2010. Thirty-
nine patients with squamous cell carcinoma resulted, from whom
60 lymph node metastases based on radiographic (not histologic)
evaluation were studied.
Of those 39 patients, 25 (64%) were male and 14 (36%) female.
T-stages were as follows: T1 8 (21%), T2 10 (26%), T3 5 (12%), T4 6
(15%) and 10 (26%) unknown primary tumors. Clinical N-stages
were: N1 5 (13%), N2a 6 (15%), N2b 21 (54%), N2c 3 (8%) and N3
4 (10%). Mean age at treatment was 63 years (range 46–85). Eleven
patients were treated with surgery, 13 were treated with surgery
and post-operative radiotherapy, 15 with surgery and post-opera-
tive CCRT. HPV testing was not routinely performed in this patient
cohort.
To determine the treatment protocol (RT vs. CCRT based upon
the presence of ENS) in case of an unknown primary tumor, super
selective neck dissections were performed to determine extranodal
spread at histopathology. In two of the 13 patients treated with
surgery and radiotherapy, a super-selective neck dissection was
performed, whereas the others had a comprehensive or selective
neck dissection. All MR images and lymph node dissections were
performed prior to other treatments. Detailed patient characteris-
tics are shown in Table 1.Deﬁnitions
All lymph nodes on MR imaging with a minimal short axial
diameter of more than 1 cm or with an inhomogeneous T1
weighted enhancement after contrast administration were studied.
These radiological ﬁndings were reported as useful criteria for cer-
vical lymph node metastasis by van den Brekel et al.24 The lymph
nodes were divided into levels according to the American Academy
of Otolaryngology–Head and Neck Surgery (AAO–HNS) 2002 classi-
ﬁcation.25,26 Whenever a lymph node was located in two levels, the
level that contained the majority of the nodal cross-sectional vol-
ume was recorded.MR-technique
MRI examinations were performed at 3.0 T. (Philips Achieva re-
lease 3.2.1, Philips Medical Systems, Best, The Netherlands) using a
dedicated 16-channel SENSE neurovascular coil. The following ser-
ies were acquired: we obtained STIR TSE COR (TR (repetition-time)
3880 ms, IR (inversion-time) 180 ms and TE (echo-time) 20 ms,
ETL: 12, FOV 300/228/40 mm, matrix: 320/320, 2 nex, slice thick-
ness 4 mm) and STIR TSE TRA, (TR/IR/TE 4,228/180/20, ETL: 12,
FOV: 180/200/80 mm, matrix 300/312, 2 nex, SW 3.5 mm). T1
TSE TRA was performed at a slice thickness of 3.5 mm (TR/TE:
780/10, ETL: 5, FOV 180/180/80, matrix 384/384, 2 nex). Further-
more, T1 3D Thrive series were performed after intravenous injec-
tion of 15 cc gadoterate meglumine (Dotarem) (TR/TE: 5/2,22,
ETL:90, TA: 10, FOV 230/272/220, matrix 288/288, 2 nex, slice
thickness: 0.8 mm) and ﬁnally T1 TSE COR (post contrast) images
were generated (TR/TE: 812/10, ETL: 6, FOV: 180/150/96 mm, ma-
trix: 320/320, 3 nex, slice thickness 3.5 mm).
The mean time between MR imaging and neck dissection was
27 days (range 0–60; SD 14.6).
Topographical correlation
By recording the combination of the largest diameter, short ax-
ial diameter and the neck level of each lymph node, it was possible
to perform a topographical correlation with the neck dissection
specimen for each lymph node metastasis larger than 1 cm.
Radiological assessment
The ﬁrst 10 cases were used as a teaching set and to assess the
applicability of the radiological characteristics. Two experienced
head and neck radiologists (FP 17 years experience; CL 8 year expe-
rience) evaluated the MR-images. All pre-treatment MRI’s were re-
viewed and evaluated by the two examiners separately, and
conclusions were made in consensus. The observers were blinded
to results of clinical examinations, surgical–pathological ﬁndings
or clinical outcome. For the statistical analysis consensus conclu-
sions were used.
628 W.L. Lodder et al. / Oral Oncology 49 (2013) 626–633The following radiological characteristics were scored (based
upon characteristics earlier described12,15,16,18–21):
(1) Size. Short axis measured in axial plane (angulated perpen-
dicular to the long axis). Long axis measured in the axial,
sagittal or coronal direction (longest measurement was
selected). This was performed to correlate to longest axis
craniocaudally with pathology specimens.
(2) Capsular contour (Smooth, lobulated, indistinct).
(3) Inﬁltration of adjacent planes, fat or muscles (yes or no).
(4) Central nodal necrosis was deﬁned as inhomogeneous
enhancement.
(5) Radiologists’ impression of presence of ENS (yes or no).
The signiﬁcance of these various characteristics was studied
with statistical analysis; sensitivity and speciﬁcity were calculated.
These characteristics, however, were not used as pre-deﬁned crite-
ria for ENS. The radiologists were asked, at the end of their review
of each study, to report their over-all impression of the presence of
ENS (yes or no).Histopathological assessment
All neck dissection specimens were labeled for the neck levels
postoperatively in the operation room by the surgeon for patholog-
ical orientation. The pathologist manually identiﬁed and localized
the lymph nodes per neck level in the specimen. The maximal
diameter of all lymph nodes was recorded. Subsequently, lymph
nodes were ﬁxed, sectioned, and hematoxyline–eosine (HE)
stained, and presence of tumor in each lymph node was examined
microscopically.
The following histological criteria were scored:
(1) Total number of lymph nodes.
(2) Number of positive lymph nodes.
(3) Largest diameter of largest node and ENS positive lymph
node and level.
(4) The following lymph node characteristics of capsule exten-
sion were listed:
a. Uncertain extension.
b. Growth into the lymph node capsule but not through or
beyond.
c. Tumor growth into the fatty hilum area.
d. Growth into surrounding fat, growth into surrounding
structures other than fat (e.g. muscles).
e. Extent of growth beyond the capsule in mm.
ENS was reported when there was ‘‘growth into surrounding fat,
growth into surrounding structures other than fat’’ and in ‘‘uncer-
tain cases’’, thus a + d + e. In case of ‘‘growth into the hilum area’’ or
‘‘growth into the lymph node capsule but not beyond’’ no ENS was
reported. Based on size and level the corresponding node at the
MRI was identiﬁed.Figure 1 Example of MRI characteristic central nodal necrosis. Axial contrast-
enhanced fat-suppressed T1 MR image of a 74-year-old male patient with a
T2N2bM0 oropharyngeal cancer, showing nodal enlargement and central nodal
necrosis (arrows); see also Fig. 5C and D.Statistical analysis
The statistical analysis accounted for the fact that the data were
clustered since 9 of the 39 patients (23%) in our study provided 2
lymph nodes and 6 patients (15%) provided 3 lymph nodes, for a
total of 60 lymph nodes. We evaluated sensitivity, speciﬁcity, posi-
tive and negative predictive value and accuracy of selected MR cri-
teria for the detection of nodal involvement, and presence or
absence of extranodal spread was estimated using histopathology
as the gold standard. 95% Conﬁdence intervals for proportions
were determined by Taylor series linearization27 to account forthe clustered sample. Interobserver variation between both radiol-
ogists was determined using kappa analysis.
The multivariate analysis of the determinants of histopatholo-
gical ENS was based on Generalized Estimating Equations (GEEs)
for binary data with a logit link function28 to account for clusters,
with an exchangeable structure of the working correlation matrix.
The usefulness of radiologically determined characteristics to
determine histopathological ENS was assessed by calculating the
area under the curve (AUC) of the receiver operating characteristic
(ROC) using the linear predictor of a multivariable logistic regres-
sion model as a score and leave-one-out cross validation. The linear
predictor was deﬁned as the linear product of the estimated
regression coefﬁcients and the values of the corresponding covari-
ates. SAS statistical software Version 9.2 was used for all analyses
(SAS Institute Inc., Cary, NC, USA).Results
Radiological assessment
After identiﬁcation of all lymph nodes with a diameter of more
than 1 cm or with a inhomogeneous enhancement, 60 lymph
nodes were studied. Fifteen nodes (25%) were located in level I,
33 nodes (55%) were found in level II, 10 nodes (16%) were located
in level III and one node (2%) was found in level IV and one node in
level V (2%). Of the 60 studied nodes, seven were smaller than 1 cm
but with inhomogeneous enhancement on MR-imaging.
Based upon the consensus of both radiologists’ impression, 20
of the 60 assessed nodes (33%) showed ENS. Of these 20 nodes,
100% had an indistinct capsular contour. Fifteen nodes (15/20 =
75%) showed ‘‘inﬁltration of adjacent planes’’. Nineteen nodes
(19/20 = 95%) had central nodal necrosis.
Of the 60 studied nodes, 26 nodes (26/60 = 43%) had a smooth
capsular contour, 13 (13/60 = 22%) had a lobulated surface and
21 (21/60 = 35%) had an indistinct capsular contour. Fifteen nodes
(25%) showed inﬁltration of adjacent planes. Thirty-seven nodes
(62%) had central nodal necrosis. The radiologists’ impression of
presence of ENS was based upon a combination of the separate
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deﬁned criteria for having ENS. These were the characteristics ear-
lier used in literature to study the appearance of ENS. In 19/21
cases with an indistinct contour, the radiologists interpreted this
as positive for ENS. In case of the MR-ﬁnding ‘‘inﬁltration of adja-
cent planes’’, all 15 were interpreted as positive for ENS. Examples
of MR-images are shown in Figs. 1–3.Figure 2 Example of MRI characteristic indistinct capsular contour. Axial contrast-
enhanced fat-suppressed T1 MR image of a 69-year-old male patient with a
T2N2bM0 oral cavity cancer, showing nodal enlargement and indistinct capsular
contour (arrows) on the ventral side of a level II lymph node on the left. Note: the
surrounding fat and overlying platysma muscle look normal. See also Fig. 4D.
Figure 3 Example of MRI characteristic growth into adjacent planes. Axial contrast-
enhanced fat-suppressed T1 MR image of a 64-year-old male patient with a
T1N2bM0 oral cavity cancer, showing nodal enlargement and inﬁtration of
surrounding tissue planes suggestive for ENS in a left level III lymph node. There
is obliteration of the surrounding fat and thickening as well as enhancement of the
overlying platysma muscle (arrows). See also Fig. 4C and D.Histopathological assessment
In 39 patients, 1571 nodes were studied. Of those, 196 (12%)
were positive for squamous cell carcinoma. The mean number of
nodes removed was 40 (range 1–85; SD 25.8), and the mean num-
ber of positive nodes was 5 (range 1–56; SD 11.7). All lymph nodes
studied by MR-images (60 lymph nodes) could be identiﬁed and
linked to lymph nodes on histopathology by diameter and level.
On histopathology, 30 (50%) nodes were positive for ENS. The
following lymph node characteristics of capsule extension were
found at revision of the slides: uncertain ENS in four nodes (7%),
growth into surrounding fat in 23 nodes (38%), growth into sur-
rounding structures other than fat in 3 (5%), and in thirty nodes
(50%) no ENS was seen. ENS positive nodes were <1 cm in 3
(10%), 5 (17%) were between 1 and 2 cm, 5 (17%) were between
2 and 3 cm and 17 (56%) were >3 cm.
Discordance between radiological and histopathological assessment of
ENS
In total, 14 (23%) lymph node metastases were differently eval-
uated on MR-imaging and histopathology. Fig. 4 shows an example
of a true positive MR evaluation. Fig. 5 shows a false negative eval-
uation of the MR image. Twelve nodes were staged ENS positive on
pathology and negative on MR-imaging. However, on MR-imaging
two nodes were staged falsely positive as they were reported as
negative in the pathology report. These two nodes showed an
indistinct capsular contour on MRI, one had central nodal necrosis,
but none showed inﬁltration of adjacent planes. Purely based upon
the capsular contour, both radiologists staged these nodes positive
for ENS.
Of the four nodes that were staged as uncertain ENS on histopa-
thology, 3 were staged as ENS negative on MR-imaging (smooth
contour 3, central nodal necrosis 3 and no growth into adjacent
planes) and one was staged ENS positive (growth into adjacent
planes was seen). As deﬁned by the American College Pathologists
these nodes with uncertain ENS were regarded as ENS positive. In
case of the three nodes that were staged as ‘‘growth into the sur-
round capsule but not through or beyond’’ and the two nodes that
were staged as ‘‘tumor growth into the hilum area’’, all ﬁve were
staged as ENS negative on MR-imaging.
Sensitivity and speciﬁcity of radiological criteria for ENS on MR
imaging
An overview of the correlation of different radiological criteria
with histologically proven ENS is given in Table 2. The MR-ﬁnding
‘‘inﬁltration of adjacent planes’’ established a speciﬁcity of 100%
(lower 90% conﬁdence bound: 91%) and a sensitivity of 50% (95%
conﬁdence interval [CI]: 28–72%). ‘‘Indistinct capsular contour’’
established a sensitivity of 63% (95% CI: 41–85%) and speciﬁcity
of 93% (95% CI: 84–100%). For the radiologists’ impression of pres-
ence of ENS (based upon a combination of all criteria together),
sensitivity was 60% (95% CI: 38–82%) and speciﬁcity 93% (95% CI:
84–100%).
Logistic regression of MRI lymph node characteristics for ENS
Univariable analysis was used to determine the association
between radiologically determined characteristics and histopa-
thological ENS. Largest diameter, indistinct capsular contour, inﬁl-
tration of adjacent planes, central nodal necrosis and the
radiologists’ impression of presence of ENS were signiﬁcantly asso-
ciated with ENS on histopathology (Table 3).
In multivariable analysis, adjusting each radiological character-
istic for clinical variables (ASA, gender, side of lymph node, age,
Figure 4 Example of true positive MRI. (A and B) Section through lymph node, showing extranodal spread (ENS). (Hematoxylin–eosin stain; original magniﬁcation 2).
Fig. 4B: (same section and magniﬁcation) The green line shows the lymph node border, green shaded areas show ENS in the surrounding fat tissue. (C and D) Coronal and axial
contrast-enhanced fat-suppressed T1 (3D THRIVE) MR images of a 64-year-old male patient with a T1N2bM0 oral cavity cancer. Both images show the same level III lymph
node on the left side. The node is enlarged and shows various areas of central necrosis. The left lateral border of the node (arrows, Fig. 4C) is indistinct and there is local
inﬁltration of adjacent tissue planes (arrows, Fig. 4D). Both radiologists (individually) reported these characteristics (i.e. lymph node enlargement, central necrosis, indistinct
borders and inﬁltration of adjacent tissue planes). Both radiologists concluded that these ﬁndings were indicative of ENS. (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
630 W.L. Lodder et al. / Oral Oncology 49 (2013) 626–633T-stage, N-stage, and whether earlier treatment was received),
associations were generally similar as in the univariable analysis
(Table 3). Due to the strong associations of the univariably associ-
ated radiological characteristics and the high correlation among
them (correlation coefﬁcient generally >.6), we did not present
the coefﬁcients for the radiobiological characteristics included in
the same model. However, including all radiological characteristics
and the clinical variables in one model and using the linear predic-
tor as a score, we calculated the ROC curve in Fig. 6, with an AUC of
0.78 (95% CI: .66, .88).Discussion
This study suggests that MRI is moderately accurate in predict-
ing ENS of neck lymph node metastases as the MR-ﬁnding ‘‘inﬁltra-
tion of adjacent planes’’ had a speciﬁcity of 100% and a sensitivity
of 50%. The overall sensitivity was 60% (95% CI: 38–82%) and spec-
iﬁcity 93% (95% CI: 84–100%). We found ﬁve signiﬁcant determi-
nants of ENS in multivariate models, i.e., ‘‘largest diameter’’,
‘‘capsular contour’’, ‘‘inﬁltration of adjacent planes’’, ‘‘central nodal
necrosis’’ and ‘‘the radiologists’ impression of presence of ENS’’.
This means that all patients in our sample fulﬁlling this MR-ﬁnding
invariably had ENS and thus might not have needed further histo-
pathologic assessment.
One of the ﬁrst authors to publish on the topic of imaging of ENS
was Yousem et al. in 1992. ENS was diagnosed on the basis of nodal
capsular enhancement and inﬁltration of adjacent fat or muscle
planes, with capsular contour irregularity. The accuracy for CT
was 90%, compared to 78% accuracy on MR imaging.19 A recentpublication by Shaw et al.8 shows a 20% false-negative rate for
MR-imaging in case of macroscopic ENS. Already in 1982, Snow
et al.29 showed that with an increase in lymph node diameter,
the chance of ENS increases. In their study, the incidence of ENS
in nodes smaller than 1 cm is 22%, 52% in nodes between 1 and
3 cm, and 74% in lymph node metastases over 3 cm. Smeele et al.30
showed with an increase in nodal size the incidence of ENS was
95% in nodes with an average size of 57 mm. Compared to the dif-
ferent ﬁndings in the literature on the preoperative assessment of
ENS on imaging (sensitivity and speciﬁcity ranging from 65% to
100%), our results seem comparable. Most studies showed their re-
sults with the use of a combination of different radiologically
determined lymph node characteristics, whereas we tried to focus
on one determining factor for characterizing ENS. In this study we
tried to ﬁnd MR-characteristics predictive for ENS with high spec-
iﬁcity that could be used for treatment planning.
Some limitations should be discussed here. Because of the ret-
rospective nature of this study, the selection of our study popula-
tion was determined by our current treatment protocol. Only
patients with neck dissection were selected, so correlation
between MR-imaging and histopathology could be established.
Histopathological diagnosis of ENS is not as equivocal and clear
as previously thought, with an observer agreement kappa value
of only 0.44.17 In this study we tried to overcome this by having
all the slides reviewed by one dedicated head and neck pathologist
(MLvV) and by using stricter criteria for deﬁning what to call ENS
positive. The MR characteristic most strongly associated with ENS
was the radiologists’ impression of the presence of ENS. We realize
that this criterion has little generalizable applications and keep us still
dependent on the skills of well trained Head and Neck Radiologists.
Figure 5 Example of false negative MRI. (A and B) Section through lymph node, showing tumor extranodal spread (ENS). (Hematoxylin–eosin stain; original magniﬁcation
2). Fig. 5B: (same section and magniﬁcation) The green line shows the lymph node border, green shaded area shows ENS in the surrounding fat tissue. (C and D) Axial and
coronal contrast-enhanced fat-suppressed T1 (3D THIRVE) MR images of a 56-year-old female patient with a T2N2b squamous cell carcinoma of the right tongue. Both images
show the same level II lymph node on the right side (arrows). The node is enlarged and centrally necrotic. The border of the node is lobulated and there is no inﬁltration of
adjacent tissue planes. Both radiologists (individually) reported these characteristics (i.e. enlargement, lobulation, distict capsular contour and no inﬁltration of adjacent
tissue planes). Both radiologists concluded that this was a pathologic lymph node without signs of ENS. (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)
Table 2
Sensitivity and speciﬁcity of radiological criteria for determination of extranodal
spread compared to histopathology.
Radiologically
determined
criteria
Pathologically determined ENS
No Yes Sensitivity Speciﬁcity Accuracy
Largest diameter > 20 mm
No 21 9 70% (50–90) 70% (48–92) 70% (56–84)
Yes 9 21
Largest diameter > 30 mm
No 24 15 50% (28–72) 80% (63–97) 65% (52–78)
Yes 6 15
Indistinct capsular contour
No 28 11 63% (41–85) 93% (84–100) 78% (66–90)
Yes 2 19
Inﬁltration of adjacent planes
No 30 15 50% (28–72) 100% (91*–100) 75% (62–88)
Yes 0 15
Central nodal necrosis
No 17 6 80% (62–98) 57% (37–77) 68% (56–80)
Yes 13 24
Radiologists’ impression of presence of ENS
No 28 12 60% (38–82) 93% (84–100) 77% (64–89)
Yes 2 18
* Lower bound of a 90% exact conﬁdence interval (not accounting for clusters),
since conﬁdence interval taking clusters into account could not be obtained.
Table 3
Univariable and multivariable analysis for predicting extranodal spread on MR
imaging.
Variables Univariate Multivariated
Odds
ratioa
95% CI Odds
radioa
95% CI
Largest diameter (per cm) 1.08 1.02–
1.14
1.11b 1.04–
1.18
Capsular contour
Lobulated vs. normal .42 .08–
2.29
.49 .07–
3.28
Indistinct vs. normal 24.04 3.70–
156.33
44.28 4.81–
407.40
Inﬁltration of adjacent planes (yes vs.
no)
Inf.c N/A Inf.c N/A
Central nodal necrosis (yes vs. no) 5.28 1.66–
16.74
12.24 2.21–
67.74
Radiologists’ impression of presence
of ENS (ENS vs. no ENS)
27.35 4.51–
165.77
53.79 6.85–
422.42
95% CI: 95% Conﬁdence Interval.
a Odds ratios based on Generalized Estimating Equations with a logit link func-
tion and an exchangeable structure of the working correlation matrix.
b Gender was excluded from the model in order to achieve convergence.
c Inﬁnite value, when inﬁltration in adjacent planes was seen on MRI, ENS was
also seen on histopathological assessment, i.e. the speciﬁcity reached 100%, and the
OR was inﬁnite.
d Each OR is adjusted for ASA, gender, side of lymph node, age in years, T-stage,
N-stage, whether earlier treatment was received.
W.L. Lodder et al. / Oral Oncology 49 (2013) 626–633 631With the present technological innovations in the ﬁeld of auto-
matic image analysis, it may be expected that in the not too far fu-
ture the subjective impression of the radiologist will be translatedinto reproducible criteria. The average time between MR scanning
and neck dissection was 27 days. This introduces a potential bias.
Figure 6 Receiver operating characteristic (ROC) curve for predicting extranodal
spread as determined by histopathology based on MRI characteristics and clinical
variables with the area under the curve (AUC) based on leave-one-out cross-
validation. Sensitivities and speciﬁcities for different cut points are shown in the
ROC curve. The AUC reached 0.78 (95% CI: .66, .88) including all radiological
characteristics and the clinical variables in one model and using the linear predictor
as a score.
632 W.L. Lodder et al. / Oral Oncology 49 (2013) 626–633However, when the data was evaluated by tertiles of time between
MR and neck dissection, convincing trends in the proportions of
false negatives or false positives were not observed. A serious lim-
itation is that MRI, by its nature, will only score macroscopic ENS
whereas by histopathology also microscopic ENS will be assessed.
Macroscopic, radiologically determined, ENS is probably prognosti-
cally more important than microscopic ENS as several authors have
reported.31–33 In total in 39 patients 196 nodes were positive for
metastatic disease. On radiology 60/196 = 31% positive lymph
nodes were recognized and studied. Of the 136 nodes, which were
only histologically assessed on a routine base, 5 (5/136 = 4%) were
in addition positive for ENS. Calculating the sensitivity and speci-
ﬁcity of the radiologists’ impression of presence of ENS adding
these 136 nodes, sensitivity decreases from 60 % (18/30) to 51%
(18/35). Speciﬁcity increases from 93% (28/30) to 99% (159/161).
Accuracy increases from 77% to 90%. However, the outcome of this
statistical analysis is no more than an indication of accuracy, since
calculations are based on the results of routine retrospective histo-
logical analysis and not on a systematic prospective microscopic
grading of the specimens by the pathologist. Since we focused on
the radiological features of ENS, the 60 radiologically recognizable
nodes were used for statistical analyses, combining a thorough
parallel analysis of both radiology and microscopy.
Due to our selection based upon the availability of histopathol-
ogy research beside microscopic ENS also the incidence of ENS in
cN0 patients could not be studied. In our institution in the largest
part of oral cavity cancers elective neck dissection is not regularly
performed. From literature it is known that in 4% up to 16% ENS
can be found in cN0 patients.34–36
Recently, several trials have shown that in the presence of ENS,
postoperative CCRT is associated with better survival than radio-
therapy alone.37,38 This regimen, although proven beneﬁcial, im-
plies an enormous increase in treatment burden and morbidity,
especially in combination with major surgery. Also, in patients
with metastases of unknown primaries in the neck, with irradia-
tion of the laryngopharyngeal axis or patients with early pharyn-
geal and laryngeal carcinomas, the choice between surgery with
radiotherapy and chemoradiation guided by the presence of ENS,
can be difﬁcult.7 Therefore, indications for CCRT should be applied
only in subgroup of patients that might beneﬁt from this
treatment.The overall sensitivity and speciﬁcity in this study is compara-
ble to the results known from literature. Two recent studies have
reported their results with respect to ENS on FDG PET/CT imag-
ing.39,40 The data in these reports suggest that SUVmax is predic-
tive of ENS and could therefore be used to detect ENS with a
higher sensitivity. With the new combined PET/MRI scanners,41,42
it can be expected that fully integrated scanning will allow for
superior evaluation of PET/MRI images. Possibly these new tech-
nologies could contribute to achieve a higher sensitivity.
In conclusion, the data suggest that speciﬁcity for the MRI ﬁnd-
ing ‘‘inﬁltration of adjacent planes’’ may be high enough (100% in
our study) to be used for treatment planning. The overall sensitiv-
ity and speciﬁcity of MRI in predicting ENS of neck lymph node
metastases was 60% and 93%, respectively, in our study. In other
cases, in which this speciﬁc feature is not present, histopathology
remains necessary to guide further treatment.
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